Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,698.00
Bid: 2,692.00
Ask: 2,694.00
Change: -20.00 (-0.74%)
Spread: 2.00 (0.074%)
Open: 2,722.00
High: 2,732.00
Low: 2,690.00
Prev. Close: 2,718.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supplementary Base Prospectus dated November 11, 2

11 Nov 2014 13:32

RNS Number : 7275W
Coca-Cola HBC Finance B.V.
11 November 2014
 



 

Coca-Cola HBC Finance B.V.

Guaranteed by Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V.

announce the publication of supplementary prospectus relating to the

EUR 3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V.

 

 

Amsterdam The Netherlands - November 11, 2014 - Coca-Cola HBC Finance B.V., Coca-Cola HBC AG and Coca-Cola HBC Holdings B.V. announce today the publication of the following supplementary prospectus which has been approved by the UK Listing Authority and is available for viewing:

 

Supplementary Prospectus, dated November 11, 2014 to the Base Prospectus dated September 18, 2014, in respect of the €3,000,000,000 Euro Medium Term Note Programme of Coca-Cola HBC Finance B.V. as issuer and Coca-Cola HBC A.G. and Coca-Cola HBC Holdings B.V. as guarantors (the "Supplementary Prospectus").

 

The Supplementary Prospectus constitutes a supplement for the purposes of Section 87G of the Financial Services and Markets Act 2000 (the "FSMA").This Supplement is supplemental to, and should be read in conjunction with, the Base Prospectus dated September 18, 2014. Terms defined in the Base Prospectus have the same meaning when used in this Supplement. The purpose of this Supplement is to incorporate by reference in the Base Prospectus the CCH Group's third quarter results for the period ended 26 September 2014 (the "CCH Group Results").

 

Copies of the CCH Group Results have been filed with the Financial Conduct Authority and, by virtue of this Supplement, the CCH Group Results are incorporated in, and form part of, the Base Prospectus, save that the ninth paragraph on page twelve of the CCH Group Results shall not be deemed to be incorporated in and shall not be deemed to form part of this Supplement.

 

A copy of the Supplementary Prospectus and the CCH Group Results have also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplementary Prospectus (and the Base Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBBBJTMBTBBLI
Date   Source Headline
13th Apr 20182:27 pmRNSNotice of Results
3rd Apr 201810:31 amRNSIssue of equity and total voting rights
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.